Judy L. Thompson, Ph.D.
Affiliations: | 2006 | University of Pittsburgh, Pittsburgh, PA, United States |
Google:
"Judy Thompson"Mean distance: 19.85 (cluster 23)
Parents
Sign in to add mentor| Michael Pogue-Geile | grad student | 2006 | University of Pittsburgh | |
| (Pre -onset abnormalities, psychosocial stressors, and the development of psychosis: A prospective, population-based study.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Blose BA, Lai A, Crosta C, et al. (2023) Retinal Neurodegeneration as a Potential Biomarker of Accelerated Aging in Schizophrenia Spectrum Disorders. Schizophrenia Bulletin |
| Demmin DL, Mote J, Beaudette DM, et al. (2019) Retinal functioning and reward processing in schizophrenia. Schizophrenia Research |
| Slifstein M, van de Giessen E, Van Snellenberg J, et al. (2015) Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. Jama Psychiatry. 72: 316-24 |
| Poels EM, Girgis RR, Thompson JL, et al. (2013) In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia. Psychopharmacology. 228: 167-74 |
| Thompson JL, Urban N, Slifstein M, et al. (2013) Striatal dopamine release in schizophrenia comorbid with substance dependence Molecular Psychiatry. 18: 909-915 |
| Thompson JL, Urban N, Slifstein M, et al. (2013) Striatal Dopamine Release in Schizophrenia Comorbis with Substance Dependence Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 152-153 |
| Abi-Dargham A, Xu X, Thompson JL, et al. (2012) Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: A PET study with [11C]NNC112 Journal of Psychopharmacology. 26: 794-805 |
| Miyake N, Thompson J, Skinbjerg M, et al. (2011) Presynaptic dopamine in schizophrenia. Cns Neuroscience & Therapeutics. 17: 104-9 |
| Thompson JL, Urban N, Abi-Dargham A. (2009) How have developments in molecular imaging techniques furthered schizophrenia research? Imaging in Medicine. 1: 135-153 |
| Thompson JL, Watson JR, Steinhauer SR, et al. (2005) Indicators of genetic liability to schizophrenia: a sibling study of neuropsychological performance. Schizophrenia Bulletin. 31: 85-96 |